ESC Premium Access

Audience questions and answers, summary and close

Topic: Diabetes and the Heart
Sponsored by The Boehringer Ingelheim, Eli Lilly and Company Alliance

Congress Presentation

About the speaker

Professor Thomas Felix Luscher

Royal Brompton Hospital Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
48 presentations

4 more presentations in this session

Welcome and introduction

Speaker: Professor T. Luscher (London, GB)


The role of SGLT2 inhibitors in CV risk reduction in patients with type 2 diabetes

Speaker: Professor S. Kaul (Los Angeles, US)


Taking the initiative: the cardiologist´s perspective

Speaker: Professor N. Marx (Aachen, DE)


The SGLT2 inhibitor era: what more can we expect?

Speaker: Professor S. Anker (Berlin, DE)


Access the full session

SGLT2 inhibitors in clinical cardiology: modern-day cardiovascular management in patients with type 2 diabetes

Speakers: Professor T. Luscher, Professor T. Luscher, Professor S. Kaul, Professor N. Marx, Professor S. Anker

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb